MigVax is a startup developing Migvax-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectivity in pre-clinical tests as a booster for previously vaccinated persons
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
Jade Biosciences
2 followers
Rapport Therapeutics
2 followers
Pulmovant
1 follower
Crossbow Therapeutics, Inc
1 follower
Lantern Pharma
25 followers
HAYA Therapeutics
2 followers
Zenas BioPharma
7 followers
Action Behavior Centers
6 followers
Watchmaker Genomics
5 followers
Soar Autism Center
1 follower
Dianthus Therapeutics
1 follower
Daiichi Sankyo (Switzerland)
2 followers